Nu-Med Plus (NUMD) Equity Average (2013 - 2025)
Nu-Med Plus' (NUMD) quarterly Equity Average came in at -$264969.0 in Q4 2025, down 26.28% year-on-year from -$359449.9 in Q4 2024, and down 4.86% quarter-over-quarter from -$252677.0 in Q3 2025.
Nu-Med Plus (NUMD) Equity Average (2013 - 2025) Analysis & Trends
Nu-Med Plus has disclosed Equity Average across 13 years of filings, most recently posting -$264969.0 for Q4 2025.
- Equity Average for Q4 2025 came in at -$264969.0, down 26.28% year-over-year; the trailing twelve-month figure through Dec 2025 was -$264969.0 (down 26.28% YoY), and the FY2025 annual result was -$243187.0, down 34.41% from the prior year.
- Equity Average came in at -$264969.0 for Q4 2025 at Nu-Med Plus, down from -$252677.0 in the prior quarter.
- In the past five years, Equity Average ranged from a high of $329329.0 in Q1 2021 to a low of -$264969.0 in Q4 2025.
- The 5-year median for Equity Average is -$163631.2 (2022), against an average of -$134202.6.
- Across the five-year window, Equity Average soared 327.71% in 2021 and sank 621.68% in 2022, its largest moves.
- Nu-Med Plus' Equity Average stood at -$101187.5 in 2021, then plunged by 64.62% to -$166578.0 in 2022, then grew by 16.34% to -$139353.0 in 2023, then tumbled by 50.57% to -$209818.5 in 2024, then decreased by 26.28% to -$264969.0 in 2025.
- The last three Equity Average figures came in at -$264969.0 (Q4 2025), -$252677.0 (Q3 2025), and -$240861.5 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 10.33 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 10.53 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 13.05 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 2.85 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 7.18 Bn |
| 10 | Nu-Med Plus | - | - | - | -264,969.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -264,969.00 |
| Sep 30, 2025 | -252,677.00 |
| Jun 30, 2025 | -240,861.50 |
| Mar 31, 2025 | -225,062.50 |
| Dec 31, 2024 | -209,818.50 |
| Sep 30, 2024 | -195,202.50 |
| Jun 30, 2024 | -177,220.50 |
| Mar 31, 2024 | -157,664.00 |
| Dec 31, 2023 | -139,353.00 |
| Sep 30, 2023 | -123,752.00 |
| Jun 30, 2023 | -103,389.00 |
| Mar 31, 2023 | -77,127.00 |
| Dec 31, 2022 | -166,578.00 |
| Sep 30, 2022 | -258,606.00 |
| Jun 30, 2022 | -218,046.00 |
| Mar 31, 2022 | -160,684.50 |
| Dec 31, 2021 | -101,187.50 |
| Sep 30, 2021 | -35,834.00 |
| Jun 30, 2021 | 94,652.00 |
| Mar 31, 2021 | 329,329.00 |